Other functional consequences of type I IFN dysregulation among these comorbidities that may contribute to enhanced TB disease progression include type I IFN-induced immune activation and sustained inflammation; decreased CD4+ T cell counts and impaired function; and reduced number and functionality of macrophages, pDCs, and conventional dendritic cells. This evidence concerns the gene CD4 and tuberculosis.